#LyGenesis
« Une personne a reçu pour la première fois un traitement expérimental qui, en cas de succès, l'amènera à développer un « foie miniature » supplémentaire. »
‘Mini liver’ will grow in person’s own lymph node in bold new trial
Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time. Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for th...
www.nature.com
April 3, 2024 at 6:02 PM
Вчені вводять пацієнту суспензію, щоб змусити його виростити нову печінку

Експериментальна клітинна терапія намагається виростити другу печінку на лімфатичних вузлах, використовуючи...

#печінка #трансплантація #орган

https://futuro.in.ua/news/5086-vcheni-vvodyat-patsiyentu-suspenziyu-zmusyty.html
April 4, 2024 at 9:30 PM
‘Mini liver’ will grow in person’s own lymph node in bold new trial: Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time. www.nature.com/articles/d41...
‘Mini liver’ will grow in person’s own lymph node in bold new trial
Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time. Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for th...
www.nature.com
April 2, 2024 at 9:37 PM
You know how cancer metastasizes to the lymph nodes? What if we put some liver cells in your lymph nodes to grow tiny livers to save people who cannot get liver transplants?

www.pushkin.fm/podcasts/wha...

3/4
Growing New Livers to Save Lives | What’s Your Problem?
Michael Hufford is the co-founder and CEO of LyGenesis, a company working on a new treatment for end stage liver disease. Michael’s problem is this: How do grow a new liver inside the body of a sick p...
www.pushkin.fm
March 20, 2026 at 5:23 PM
記事の要約:バイオテクノロジー企業LyGenesisが、人体内で新しい小さな肝臓を育てる試みを行っている。この治療法は、リンパ節にドナー細胞を注入し、健康な肝組織の成長を促すものであり、肝移植待ちの患者に希望をもたらす可能性がある。初期の実験では、マウスやブタでの成功例があり、今後の臨床試験に期待が寄せられている。治療効果の評価や安全性の確認が進められ、成功すれば肝移植の代替手段として画期的な治療法となる可能性がある。
April 5, 2024 at 12:46 PM
記事の要約:バイオテクノロジー企業LyGenesisが、人体内で新しい小さな肝臓を育てる試みを行っている。この手法では、寄付された肝細胞をリンパ節に注入し、患者の肝臓疾患を治療することを目指している。この新しいアプローチは、肝臓移植待ちの患者に対する画期的な治療法として期待されており、成功すれば肝移植の代替手段となる可能性がある。現在は12人の成人を対象に試験が進行中であり、新しい肝臓が機能を担うまで数ヶ月かかる見込みである。
April 4, 2024 at 9:13 AM
LyGenesis Celebrates Prestigious Research Award to Enhance Insulin Independence in Type 1 Diabetes#USA#Pittsburgh#Breakthrough_T1D#LyGenesis#pancreatic_islet
LyGenesis Celebrates Prestigious Research Award to Enhance Insulin Independence in Type 1 Diabetes
LyGenesis receives a significant award to advance research aimed at inducing immune tolerance in Type 1 diabetes through innovative pancreatic islet transplantation techniques.
third-news.com
June 25, 2026 at 1:01 PM
في تجربة فريدة من نوعها على مريض يعاني من فشل الكبد، قامت شركة التكنولوجيا الحيوية LyGenesis بزرع خلايا من كبد متبرع في العقد اللمفاوية للمريض بهدف تنمية كبد جديد داخل جسم المريض...
teqnoverse.com/others/liver...
April 8, 2024 at 3:01 PM
Recording now available from AFAR’s recent free #webinar exploring #biotech innovations driving #regenerativemedicine for longevity. Featuring leaders from LyGenesis, @mayoclinic.org @morphoceuticals.bsky.social & UCLA.
Watch here: buff.ly/yGUgjNt
April 7, 2025 at 3:02 PM
Recording now available from AFAR’s recent #webinar, “Emerging Technologies and Aging Research: Bioprinting, Organ Regeneration, and Beyond” ft. leaders from LyGenesis, @mayoclinic.org @morphoceuticals.bsky.social & UCLA.
Watch here:
April 3, 2025 at 5:03 PM
LAST CHANCE to RSVP for tomorrow's free #webinar exploring #biotech innovations driving #regenerativemedicine for longevity. Featuring leaders from LyGenesis, Morphoceuticals, Mayo Clinic, & UCLA.
Learn more & RSVP here: bit.ly/41l5slH
March 19, 2025 at 3:01 PM
THIS THURSDAY March 20 from 12-1pm ET: free #webinar exploring #biotech innovations that are driving #regenerativemedicine for longevity. Featuring leaders from LyGenesis, Morphoceuticals, Mayo Clinic, & UCLA.
Learn more & RSVP here: bit.ly/41l5slH
March 17, 2025 at 2:00 PM
NEXT WEEK - March 20th from 12-1pm ET: free #webinar exploring #biotech innovations that are driving #regenerativemedicine for longevity. Featuring leaders from LyGenesis, @mayoclinic.org @morphoceuticals.bsky.social & UCLA.
Learn more & RSVP here: bit.ly/41l5slH
March 13, 2025 at 2:01 PM
At our free #webinar on March 20th from 12-1pm ET, LyGenesis co-Founder and CEO Michael Hufford, PhD, will discuss how his company is supporting #longevity through #Celltherapies for #organregeneration and #transplant.
Learn more & RSVP here: bit.ly/41l5slH
March 7, 2025 at 7:58 PM
TWO WEEKS AWAY - March 20th from 12-1pm ET: Join AFAR for a free #webinar exploring #biotech innovations that are driving #regenerativemedicine for longevity.
Featuring leaders from LyGenesis, Morphoceuticals, Mayo Clinic, & UCLA.
Learn more & RSVP here: bit.ly/41l5slH
March 6, 2025 at 4:00 PM
Pitt's been on an innovation roll of late, with a big jump in #inventiondisclosures, #patents and #startups. Vice Chancellor Evan Facher and Michael Hufford, CEO of LyGenesis, joined us on WPXI-TV's "Our Region's Business" to talk about why it's happening.
www.wpxi.com/news/pittsbu...
Our Region's Business -- LyGenesis
www.wpxi.com
August 11, 2025 at 11:26 AM
Pitt's posting big numbers when it comes to innovation, with invention disclosures up 30-percent, producing more patents and startups. Vice Chancellor Evan Facher and Michael Hufford, CEO of Lygenesis join us on WPXI's "Our Region's Business," Sunday at 11 on Channel 11.
August 8, 2025 at 8:13 PM
‘Mini liver’ will grow in person’s own lymph node in bold new trial
‘Mini liver’ will grow in person’s own lymph node in bold new trial
Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time.
www.nature.com
April 2, 2024 at 6:26 PM
>> Eine Firma lässt Miniaturlebern in den Lymphknoten wachsen und hat soeben mit der Phase-II-Studie dazu begonnen. Wow!

gizmodo.com/lygenesis-mi...
Experimental Therapy Could Grow You Brand New Livers
Biotech company LyGenesis announced Tuesday that it has begun a phase II trial of its therapy designed to grow miniature livers inside a person’s lymph nodes.
gizmodo.com
April 4, 2024 at 9:22 AM
PA indeed has an impressive biotech/pharma scene. There are high-profile startups/firms with a focus on age-related illness, like LyGenesis aiming for organ regeneration and Annovis Bio targeting neurodegeneration. Both are running clinical trials. Fostering these ecosystems is critically important.
January 20, 2026 at 6:48 PM
LyGenesis gets approval for Phase 2a for its cell therapy that uses a patient's lymph nodes as bioreactors to grow functioning ectopic organs #biosky
www.prnewswire.com/news-release...
Data and Safety Monitoring Board Approves LyGenesis's Phase 2a Clinical Trial to Continue and Dose Escalate in Novel Trial of Organ Regeneration
/PRNewswire/ -- LyGenesis, Inc., a clinical-stage biotechnology company developing cell therapies for organ regeneration, today announced that the Data and...
www.prnewswire.com
March 5, 2025 at 12:00 PM
LyGenesis progresses Phase 2a clinical trial in organ regeneration
Biotech gains DSMB approval to escalate dosing as it advances novel organ regeneration therapy for end-stage liver disease.
#biotech
LyGenesis progresses Phase 2a clinical trial in organ regeneration
Biotech gains DSMB approval to escalate dosing as it advances novel organ regeneration therapy for end-stage liver disease.
longevity.technology
March 7, 2025 at 6:12 PM